Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (69)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Primary cardiac tumors are uncommon
- Sporadic myxoma lacks a consistent genetic signature
- Sessile versus pedunculated myxoma
- Hemorrhage and inflammation are usually present
- More than 80% occur on valves
- Apply the pattern: Valvular fronded lesion
- “Spider cells” reflect processing of glycogen
- Reference
Slide index & full transcript (69 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Primary Cardiac Tumors
Morphology · mechanisms · clinicopathologic correlation
Benign neoplasms, clinically consequential masses, and rare sarcomas
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Classify the principal benign and rare malignant primary cardiac tumors.
Recognize the defining gross and microscopic patterns of myxoma, papillary fibroelastoma, and rhabdomyoma.
Link tumor location and architecture to obstruction, embolization, and other clinical effects.
Explain the syndromic signaling abnormalities described for myxoma and rhabdomyoma.
Slide 3 · Primary cardiac tumors are uncommon
Frequency
Primary cardiac tumors are uncommon in routine clinical practice.
Biology
The majority are benign rather than malignant.
Why they matter
A benign mass may still impair intracardiac blood flow or embolize.
Slide 4 · Five common benign entities
Order
Primary cardiac tumor
Teaching discriminator
1
Myxoma
Most frequent in the combined population
2
Fibroma
Benign; Resembles extracardiac counterpart
3
Lipoma
Benign; Resembles extracardiac counterpart
4
Papillary fibroelastoma
Endocardial, often valvular
5
Rhabdomyoma
Leading pediatric primary tumor
Slide 5 · Almost 90% belong to these five types
Five frequent benign entities
No malignant potential
≈90% of primary cardiac tumors
Slide 6 · Adult and pediatric leading entities differ
Adults: Myxoma
Myxoma predominates in adult hearts.
Commonly attached to the atrial septum.
Atrial obstruction, embolization, and constitutional effects.
Children: Rhabdomyoma
Rhabdomyoma is the leading pediatric type.
Often multiple in ventricular myocardium.
Associated with tuberous sclerosis in about half.
Slide 7 · The compartment predicts the mechanism
Atrial cavity
A mobile intracavitary myxoma may obstruct an atrioventricular orifice.
Valve surface
Papillary fibroelastoma is often silent but can embolize.
Ventricular myocardium
Rhabdomyoma may project into the lumen and obstruct flow.
Slide 8 · Benign histology does not ensure benign physiology
Benign intracardiac mass
Mechanical or embolic complication
Clinically significant disease
Slide 9 · Primary malignant cardiac tumors are exceptionally rare
Angiosarcoma among the usual malignant histologic types.
It also identifies undifferentiated sarcomas with MDM2 oncogene amplification.
Cardiac sarcomas are not described as clinically or morphologically unique relative to sarcomas elsewhere.
Slide 10 · Myxoma is the most common adult primary tumor
Benign neoplasm arising from primitive multipotent mesenchymal cells.
Most often an atrial rather than ventricular lesion.
Clinical significance reflects obstruction, embolization, or cytokine-associated effects.
RA
LA
RV
LV
Schematic · cardiac chambers
Septal attachment
Slide 11 · Myxoma arises from multipotent mesenchymal cells
Primitive multipotent mesenchymal cell
Benign myxoma
Myxoid tumor within atrial cavity
Slide 12 · Sporadic myxoma lacks a consistent genetic signature
Sporadic myxomas have no consistent genetic alteration in the supplied Robbins section.
This statement differs from the defined gene defects of recognized syndromic associations.
Do not assume that every myxoma is syndromic from its histology alone.
Slide 13 · Two recognized syndromic associations
McCune–Albright
McCune–Albright syndrome
Activating GNAS1 mutation
Enhanced G-protein signaling
Carney complex
Carney complex
Loss-of-function PRKAR1A mutation
Increased cAMP-dependent signaling
Slide 14 · GNAS1: Gain of function enhances signaling
GNAS1 gain of function
Gsα signaling ↑
Enhanced G-protein signaling
Slide 15 · PRKAR1A: Loss of regulatory restraint
PRKAR1A loss of function
PKA regulatory subunit affected
CAMP-dependent signaling ↑
Slide 16 · Syndromic myxoma: Contrast the direction
Syndrome
Gene
Alteration
Signaling consequence
McCune–Albright
GNAS1
Gain of function
Enhanced G-protein signaling
Carney complex
PRKAR1A
Loss of function
Increased cAMP-dependent signaling
Slide 17 · Approximately 90% of myxomas are atrial
Atria are overwhelmingly favored over ventricles.
The location helps explain why an intracavitary lesion can involve a valve opening.
The fossa ovalis region of the atrial septum is the favored origin.
RA
LA
RV
LV
Schematic · cardiac chambers
Septal attachment
Slide 18 · Left atrial myxoma is more frequent
Left atrial site
Left atrium is the predominant atrial site.
Often near the interatrial septum.
May interfere with the mitral orifice.
Right atrial site
Right atrium is less frequently involved.
The approximate left:right atrial ratio is 4:1.
Both sites fit the atrial predominance.
Slide 19 · Fossa ovalis: The preferred attachment site
Myxomas usually arise from the region of the fossa ovalis.
This site lies in the interatrial septum.
A lesion can remain septally attached while projecting into the atrial cavity.
RA
LA
RV
LV
Schematic · cardiac chambers
Septal attachment
Slide 20 · Myxomas are usually single
Usual pattern
Most myxomas are solitary.
A single endocardial attachment may anchor a relatively large mass.
Less common pattern
Multiple tumors can occur, but are rare.
The provided source does not assign a numerical multiplicity rate.
Slide 21 · Myxoma size spans a very broad range
Small lesions
Some are under 1 cm in diameter.
Large lesions
Some reach 10 cm or more.
Clinical implication
Size and mobility together determine how a mass encounters an orifice.
Slide 22 · Sessile versus pedunculated myxoma
Sessile
Broad attachment at the origin.
May form a large intracavitary mass.
Robbins figure depicts a large sessile myxoma.
Pedunculated
Attached by a stalk.
Can move appreciably with the cardiac cycle.
May intermittently enter an atrioventricular opening.
Slide 23 · Gross myxomas have variable texture
Firm or globular
Some masses are relatively hard and mottled by hemorrhage.
Soft or gelatinous
Other masses are translucent with a gelatinous quality.
Papillary or villous
Some lesions show surface projections rather than a smooth mass.
Slide 24 · A gelatinous mass reflects abundant matrix
The microscopic tumor contains abundant acid mucopolysaccharide-rich extracellular ground substance.
The large matrix compartment accounts for much of the myxoid or gelatinous appearance.
Cellular elements are relatively dispersed within this matrix.
Vessel-like space
Schematic · not an H&E specimen
Slide 25 · Mobile myxoma can create “ball-valve” obstruction
A pedunculated mass may move into an atrioventricular valve opening.
The orifice is transiently occupied by tumor tissue.
Obstruction can vary from moment to moment rather than remaining fixed.
RA
LA
RV
LV
Schematic · cardiac chambers
Septal attachment
Slide 26 · Position can change the severity of obstruction
Change in body position or cardiac phase
Mobile mass meets valve orifice
Intermittent flow obstruction
Slide 27 · The obstruction is anatomical, not malignant
A benign myxoma can restrict valve-orifice flow without invading the valve.
Physical mobility and the attachment site explain episodic symptoms.
Histologic benignity and hemodynamic significance should be assessed separately.
Slide 28 · Myxoma histology: Abundant myxoid matrix
Extracellular ground substance is rich in acid mucopolysaccharides.
The matrix separates scattered tumor cells.
The dominant microscopic pattern is myxoid rather than densely cellular.
Vessel-like space
Schematic · not an H&E specimen
Slide 29 · Myxoma cells may be stellate or globular
Stellate cells extend delicate cytoplasmic processes.
Other tumor cells appear globular within the myxoid ground substance.
Cell shape alone is not the entire diagnosis; Architectural context matters.
Vessel-like space
Schematic · not an H&E specimen
Slide 30 · Vessel-like and gland-like formations
Unusual vessel-like or gland-like structures are characteristic morphologic features.
These patterns sit within the abundant extracellular matrix.
The schematic represents architecture, not a patient photomicrograph.
Vessel-like space
Schematic · not an H&E specimen
Slide 31 · Hemorrhage and inflammation are usually present
Hemorrhage frequently accompanies the tumor matrix and cells.
Mononuclear inflammatory infiltrates are usually encountered.
A hemorrhagic gross surface and inflammatory microscopic background may coexist.
Slide 32 · Morphology integrates matrix, cells, and structures
Component
Histologic description
Extracellular compartment
Abundant acid mucopolysaccharide ground substance
Tumor-cell appearance
Stellate or globular myxoma cells
Distinctive arrangements
Unusual vessel-like or gland-like structures
Associated findings
Hemorrhage and mononuclear inflammation
Slide 33 · Three pathways produce myxoma symptoms
Obstruction
Intermittent ball-valve interference with intracardiac flow.
Embolization
Fragments may enter the systemic circulation.
Constitutional
Fever and malaise may reflect tumor-derived cytokines.
Slide 34 · Fragmentation produces systemic embolization
Tumor fragmentation
Detached material reaches circulation
Systemic embolic event
Slide 35 · Fever and malaise can be tumor related
A constitutional syndrome including fever and malaise.
These manifestations may accompany an otherwise benign neoplasm.
They should be interpreted alongside obstruction and embolization.
Slide 36 · Interleukin-6 links tumor and acute-phase response
IL-6 elaborated by some myxomas
Acute-phase response
Constitutional symptoms
Slide 37 · Echocardiography identifies the intracardiac mass
Echocardiography provides a noninvasive way to identify the myxoma.
Its structural utility follows from the lesion projecting into a cardiac chamber.
The source does not specify modality-specific performance metrics or universal imaging protocols.
Slide 38 · Resection is usually curative
Usual outcome
Surgical removal is typically curative.
The physical mass and its associated complications are addressed.
Rare recurrence
Rare recurrence occurs months to years later.
Incomplete excision is suggested as a likely explanation in the source.
Slide 39 · Apply the pattern: Obstructing atrial mass
An adult has intermittent symptoms that vary with position; Imaging shows a mobile atrial mass attached to the septum.
Discriminating clues
Adult age group
Atrial septal attachment
Position-dependent obstruction
Most compatible tumor?
Atrial myxoma — the attachment, mobility, and clinical physiology match the textbook pattern.
Slide 40 · Papillary fibroelastoma: Endocardial tumor
A distinctive, sea-anemone-shaped endocardial lesion.
Commonly found incidentally rather than through symptoms.
Its ability to embolize makes an apparently small benign tumor clinically significant.
Slide 41 · More than 80% occur on valves
Common location
Valvular surfaces account for more than 80% of lesions.
Gross identity
Delicate hair-like projections arise from a small endocardial base.
Clinical meaning
Valvular attachment does not guarantee functional insignificance.
Slide 42 · Valve surface orientation is characteristic
Semilunar valves
Semilunar valves: Ventricular surfaces are especially favored.
These include the aortic and pulmonary valve family.
Atrioventricular valves
Atrioventricular valves: Atrial surfaces are especially favored.
These include the mitral and tricuspid valve family.
Slide 43 · Typical fibroelastoma diameter: 0.5–2 cm
The principal mass is typically 0.5–2 cm in diameter.
The projecting filaments may reach 1 cm in length.
A limited mass diameter does not eliminate embolic significance.
Slide 44 · Papillary fibroelastoma has hair-like fronds
Numerous delicate projections create a sea-anemone-like outline.
Hair-like fronds arise from a compact valvular or endocardial attachment.
This gross architecture is distinct from the gelatinous mass of a myxoma.
Schematic · endothelial-covered fronds
Slide 45 · Each papillary projection has an endothelial cover
An endothelial layer lines the outside of each projection.
The central portion is connective tissue rather than densely packed neoplastic cells.
The overall growth pattern is a branching papillary structure.
Schematic · endothelial-covered fronds
Slide 46 · The fibroelastoma core contains elastic fibers
Layer / component
Textbook description
Surface
Endothelium
Central stroma
Myxoid connective tissue
Matrix
Abundant mucopolysaccharide ground substance
Other core component
Elastic fibers
Slide 47 · Clonal abnormalities support neoplastic status
Clonal cytogenetic abnormalities have been reported in papillary fibroelastomas.
These findings support their interpretation as benign neoplasms.
The source does not provide a specific recurrent chromosomal change or diagnostic molecular test.
Slide 48 · Lambl excrescences are the main named look-alike
Papillary fibroelastoma
Small, papillary, endothelial-covered fibroelastic tumor.
Often on valves; Can cause embolic consequences.
Clonal cytogenetic abnormalities have been observed.
Lambl excrescence
Much smaller projections from sites of valve apposition.
Usually regarded as trivial comparison.
Morphologic resemblance does not make them identical lesions.
Slide 49 · Fibroelastoma may first matter through embolization
Incidental endocardial lesion
Potential embolization
Clinically important event
Slide 50 · Apply the pattern: Valvular fronded lesion
A small incidental valvular tumor has many hair-like projections, and its stalk is attached to the valve surface.
Discriminating clues
Often valvular location
Sea-anemone-like contour
Fibroelastic papillary core
Most compatible tumor?
Papillary fibroelastoma; Distinguish it from the much smaller Lambl excrescence.
Slide 51 · Rhabdomyoma predominates in pediatric hearts
The most frequent primary tumor of the pediatric heart.
Often detected during the first years of life.
Evaluation may be prompted by valve dysfunction or flow obstruction.
RA
LA
RV
LV
Schematic · cardiac chambers
Slide 52 · About half are associated with tuberous sclerosis
Syndromic group
Approximately 50% of cardiac rhabdomyomas are associated with tuberous sclerosis.
The syndrome involves TSC1 or TSC2 tumor suppressor gene mutations.
Sporadic group
Approximately half are attributed to sporadic mutations.
Do not label every cardiac rhabdomyoma as tuberous-sclerosis-associated.
Slide 53 · TSC1 and TSC2 encode hamartin and tuberin
Gene / complex
Product
Role in source
TSC1
Hamartin
Tumor suppressor protein
TSC2
Tuberin
Tumor suppressor protein
TSC1/TSC2 complex
Functional pair
Inhibits mTOR activity
Slide 54 · TSC1–TSC2 complex inhibits mTOR
Hamartin + tuberin
MTOR activity restrained
Cell growth and size controlled
Slide 55 · Loss of inhibitory control permits overgrowth
Loss of TSC1 or TSC2 expression
Reduced restraint of mTOR
Myocyte overgrowth
Slide 56 · Spontaneous regression challenges strict tumor labels
Observed biological behavior
Rhabdomyomas often regress spontaneously.
The natural history does not resemble relentless malignant growth.
Interpretive consequence
Some authors consider them hamartomas rather than true neoplasms.
This is a classification interpretation, not a universal requirement.
Slide 57 · Rhabdomyoma prefers ventricular myocardium
Myocardial masses preferentially involve the ventricles.
Lesions can bulge into the ventricular cavity.
The intraluminal projection can account for flow obstruction.
RA
LA
RV
LV
Schematic · cardiac chambers
Slide 58 · Rhabdomyoma: Multiple gray-white masses
Gross color
Typically gray-white myocardial masses.
Multiplicity
Usually multiple rather than solitary.
Size and site
From small lesions to masses several centimeters in ventricular myocardium.
Slide 59 · Enlarged cardiac myocytes contain glycogen
Microscopy shows bizarre, markedly enlarged myocytes.
Large intracellular glycogen collections are a central feature.
Routine tissue processing removes much of the glycogen.
Slide 60 · “Spider cells” reflect processing of glycogen
Glycogen extraction leaves the cytoplasm appearing empty.
Residual cytoplasm remains as thin strands from nucleus to cell membrane.
This produces the classic spider-cell appearance.
Central nucleus
Thin residual cytoplasmic strands
Schematic · glycogen extraction artifact
Slide 61 · Rhabdomyoma effects depend on position
Ventricular myocardial mass
Protrusion into lumen
Valve dysfunction or flow obstruction
Slide 62 · Apply the pattern: Infant ventricular masses
An infant is evaluated for cardiac flow obstruction; Imaging shows multiple ventricular myocardial masses.
Discriminating clues
Age in first years of life
Ventricular and multiple lesions
Possible tuberous sclerosis association
What further mechanism fits?
Cardiac rhabdomyoma; Consider TSC1/TSC2-mediated loss of mTOR restraint.
Slide 63 · Fibroma and lipoma: Limited textbook detail
Fibroma
Among the five most common primary benign cardiac tumors.
Morphologically resemble fibromas arising elsewhere.
No site-specific mechanism is detailed here.
Lipoma
Also among the five most common benign primary tumors.
Resemble lipomas at extracardiac sites.
No additional cardiac-specific morphology is supplied.
Slide 64 · Primary cardiac sarcoma: The rare exception
Angiosarcoma
Angiosarcoma is one of the typical malignant types.
The section provides no special cardiac-specific diagnostic morphology.
MDM2-amplified sarcoma
Undifferentiated sarcoma with MDM2 amplification is another named type.
MDM2 is a molecular finding mentioned in this source.
Slide 65 · Primary tumor versus cardiac metastatic deposit
Primary cardiac tumor
Originates within the heart.
Most examples are benign.
Myxoma, fibroelastoma, and rhabdomyoma are the detailed prototypes.
Metastatic involvement
Reaches heart or pericardium from a noncardiac cancer.
The adjacent section identifies several metastatic routes.
Cardiac secondary involvement is a separate diagnostic category.
Slide 66 · Compare the three diagnostic prototypes
Entity
Predilection
Morphology
Clinical link
Myxoma
Adult; Atrial
Gelatinous mass; Myxoid matrix
Obstruction / emboli / IL-6
Fibroelastoma
Valvular endocardium
Hair-like endothelial papillae
Potential emboli
Rhabdomyoma
Child; Ventricle
Glycogen-rich spider cells
Flow obstruction; Regression
Slide 67 · A pattern-based approach to a cardiac mass
Patient age + anatomical site
Gross / microscopic pattern
Most compatible tumor identity
Slide 68 · Three patterns worth retaining
Atrial myxoma
Myxoid matrix + septal attachment + variable obstruction.
Papillary fibroelastoma
Valvular hair-like fronds + endothelial covering + embolic risk.
Cardiac rhabdomyoma
Ventricular pediatric masses + glycogen-laden spider cells + TSC association.
Slide 69 · Reference
Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition. Elsevier; 2026.
The Heart — Primary Cardiac Tumors.